Recent studies have reported anti-IFI16 antibodies in the sera of patients with autoimmune diseases such as systemic lupus erythematosus, inflammatory bowel diseases, and rheumatoid arthritis [39,40,41]. Here, IFI16 is linked to inflammatory bowel disease.